So we could speculate that these differences might reflect a failed attempt by the mice to control the glioma by increasing tumor-suppressive Vγ4Vδ4+ cells that can be stimulated to produce IL-17, and decreasing tumor-promoting Vγ1Vδ6.3+ cells that can be stimulated to produce IL-4. The gene discussed is IL17A; the disease is central nervous system cancer.